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Abstract
Background: The information from different data sets experimented under different conditions
may be inconsistent even though they are performed with the same research objectives. More than
that, even when the data sets were generated from the same platform, the data agreement may be
affected by the technical variation among the laboratories. In this case, it is necessary to use the
combined data set after adjusting the differences between such data sets, for detecting the more
reliable information.
Results: The proposed method combines data sets posterior to the discretization of data sets
based on the ranks of the gene expression ratios, and the statistical method is applied to the
combined data set for predictive gene selection. The efficiency of the proposed method was
evaluated using five colon cancer related data sets, which were experimented using cDNA
microarrays with different RNA sources, and one experiment utilized oligonucleotide arrays. NCI-
60 cell lines data sets were used, which were performed with two different platforms of cDNA
microarrays and Affymetrix HU6800 oligonucleotide arrays. The combined data set by the
proposed method predicted the test data sets more accurately than the separated data sets did.
The biological significant genes were detected from the combined data set, which were missed on
the separated data sets.
Conclusion:  By transforming gene expressions using ranks, the proposed method is not
influenced by systematic bias among chips and normalization method. The method may be
especially more useful to find predictive genes from data sets which have different scale in gene
expressions.
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Background
Data sets that are created for the same purpose in different
laboratories have accumulated rapidly. The results are
often inconsistent due to the utilization of different plat-
forms, sample preparations, or various technical varia-
tions. In this case, if a combined data set were analyzed
after adjusting systematic biases that exist among different
data sets derived from different experimental conditions,
the power of statistical tests would be improved by an
increase in the sample size.
When the results from different data sets are inconsistent,
usually the common portions can be adapted for stability.
This type of meta-analysis involves a set of classical statis-
tical techniques [1] and has been applied to microarray
data sets [2,3]. As a method to combine data sets, Lee et al.
[4] simply standardized gene expression ratios of human
and mouse microarray data sets and combined these two
data sets for comparative functional genomics. To analyze
a combined data set of two different data sets, the trans-
formation of gene expression was introduced [5]. This
method transforms the gene expression ratios of two data
sets in the form of a reference experiment and the refer-
ence experiment is created as a mean vector for all experi-
ments. Consequently, this method does not consider the
difference in gene expression patterns that exists between
different experimental groups. To account for the variabil-
ity that resulted from the various confounding factors
such as different experimental conditions, an ANOVA
(Analysis Of Variance) model was introduced [6]. It is a
flexible method for considering gene expression ratios
and other clinical variables together, although it does not
create a combined large data set for applying various ana-
lytical methods.
Sometimes gene expression ratios may include outliers as
a result of incomplete experimental conditions, and these
values can cause unreliable results by their strong influ-
ence. The usage of the categorized values of gene expres-
sion ratios can reduce the influence of outliers in this case
and may improve the prediction accuracies in the classifi-
cation of different experimental classes. The usage of the
discrete values has advantage that is more concise to rep-
resent and specify, easier to use, and conducive to
improved predictive accuracy [7]. The discretization of
gene expression levels has been achieved [8].
The simplest discretization methods are the Equal Interval
Width and Equal Frequency Intervals methods. Kerber [9]
suggested the ChiMerge method and this method begins
by placing each observed value into its own interval and
proceeds by using the χ2 test to determine when adjacent
intervals should be merged. A number of entropy-based
methods have recently come to the forefront of work on
discretization [10]. Fayyad and Irani [10] use a recursive
entropy minimization heuristic for discretization and
couple this method with the Minimum Description
Length criterion [11] to control the number of intervals
produced over the continuous space. In addition, a non-
parametric scoring method was applied to gene expres-
sion data to discretize gene expression ratios [12], which
usually transforms expression ratios based on their ranks
by each experiment. In this case, some genes are included
in the same rank and the score can be calculated differ-
ently according to the order of ranks with same values,
which requires more time to score as the number of sam-
ples increases.
In this study, gene expression ratios were transformed
with their ranks for each data set. Next, the transformed
data sets were combined and a nonparametric statistical
method was applied to the combined data set to detect
informative genes with high prediction accuracy. The per-
formance of the proposed method using data sets derived
from different platforms and different RNA sources was
evaluated.
Results
A. The necessity of combining data sets
The relationship between the number of genes and OOB
(Out of Bag) error rates was investigated using data A, data
B and data AB, which represent the data sets with total
RNA, amplified RNA, and the combined data, respec-
tively.
The OOB error rates were calculated for randomly selected
genes 500 times repeatedly with the same size and aver-
aged them. The OOB error rates decreased as the number
of informative genes increased.
As shown in Figure 1A, the OOB error rates were decreased
with a small number of genes when informative genes
were used by their significance in discrimination. While
there was a large variation in OOB error rates in the sepa-
rated data sets, it was even more stable in the combined
data set. Therefore, it was confirmed that the more stable
discriminative gene set can be detected from the com-
bined data set. In this case, that the OOB error rates had
large variations as the number of informative genes was
increased can be attributed to the addition of redundant
genes. In data mining processes, it is generally known that
the exclusion of redundant variables improves the power
in discrimination [13]. Therefore, both significance and
redundancy should be considered to detect the most dis-
criminative gene set. Figure 1B showed that the variations
among the three averaged OOB error rates were stable at
80–90 informative genes. This indicates that two sepa-
rated data sets and a combined data set have almost the
same power in discrimination with 80–90 informativeBMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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genes. However, OOB error rates in a combined data set
were stable with about 20 genes (Figure 1A).
B. Improvement of prediction accuracy using combined 
data sets by the proposed method
The prediction accuracies were compared using two origi-
nal colon cancer data sets as training data sets, which were
experimented with different RNA sources.
While the prediction accuracy of data B using data A as a
train data set was higher than 95%, the accuracy of data A
using data B was lower than 80% (Figure 2A). This indi-
cated that the data set created using total RNA predicted
the data set using amplified RNA more correctly. Figure 2B
shows that the prediction accuracies of the two test data
sets, Tumor 211 and Tumor 86. The prediction accuracy of
the combined data set was higher than the separated data
sets on two test data sets. Also, data B predicted test data
sets with higher accuracy than data A, it could be caused
that the two test data sets were also experimented using
amplified RNA. The prediction accuracy was higher in
Batch II-86 tumor than in Batch I-211 tumor data set.
C. Comparison of the prediction accuracy with the 
Minimal Entropy (ME) method
Figure 3 shows the prediction accuracies of the separated
and combined data sets transformed by the Minimal
Entropy (ME) method.
Tumor 211 and Tumor 86 data sets were predicted more
accurately with train data A and data B, respectively. This
indicated that the prediction accuracy depends on train
data sets in the ME method. Figure 3 also showed that
there was not any improvement in prediction accuracy
when a combined data set by ME method was used as
train data set.
Figure 4 shows the comparison of prediction accuracies
between the proposed method and ME method. While the
combined data set by the ME method did not show any
improvement in prediction accuracy compared with sepa-
rated data sets, the proposed method improved it by com-
bining data sets. The two combined data sets predicted the
test data sets with high accuracy and the proposed method
showed higher accuracies and smaller variations in accu-
racies on test data sets than did the ME method
D. Description of significant genes selected from a 
combined data set by the proposed method
The descriptions of six discriminative genes selected from
the combined data set, not two separated data sets, are
summarized in Table 1.
AA485151 was upregulated by over five-fold in colorectal
adenocarcinoma [14]. AA425217 was published as a sig-
nificant gene in colorectal cancer [15], and 16q22.1,
where AA425217 is located, is a region that includes
Relationship of OOB error rates to the number of significant genes Figure 1
Relationship of OOB error rates to the number of significant genes. (A) Red: data A, black: data B, blue: data AB, 
which is a combined data set by the proposed method. (B) Variations of averaged OOB error rates among three different data 
sets, data A, data B, and data AB.BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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CDH1, which encodes cell-cell adhesion protein and is
expressed in gastric cancer and lobular breast cancer.
AA464731 is known to be a downregulated gene in the
SW620 cell line [16], a metastatic colorectal cancer cell
line. It is also significantly overexpressed in pancreatic cell
lines [17]. AA504130 is located on 13q12.3, similarly to
BRCA2, which is known as a marker of breast and ovarian
cancer. The mutated gene for retinoblastoma is located on
chromosome 13q14 [18], on which AA504130 is also
located.
AA455925 is known as a E2F-1 regulated gene [19]. Xq26
is a region of two common chromosomal deletion
regions, Xq25 and Xq26 [20], and is known to contribute
to the malignant progression of gastric epithelial progeni-
tor (GEP) endocrine carcinomas. Colorectal cancer is
thought to be more common in men than in women.
Xq26 is known as one of regions that contained multiple
gains-of-function that were significantly more common in
males than in females [21]. Since AW050510 is located at
17q25.3 and BIRC5 is at 17q25 and is known as a 'sur-
vivin expression colorectal cancer' [22,23], AW050510 is
also expected to have similar characteristic to BIRC5.
The descriptions of 4 colorectal cancer related genes and 9
cancer related genes are summarized in Table 2. These
genes were selected from a combined data set.
E. Improvement of prediction accuracies by combining 
data sets performed using different platforms
The prediction accuracies of combined data sets derived
from different platforms were investigated.
While the prediction accuracies of data A and data B on
affy were low with a small number of genes, it increased
as the number of genes was increased. By combining data
A and data B, the prediction accuracy on affy was
improved, as shown in Figure 5A. When affymetrix data
was used as a train data set, its prediction accuracies on
data A and data B were lower than 60%. However, after
combining with data A or data B, it improved to higher
than 90% (Figure 5B).
Table 1: Description of six informative genes (one is duplicated among seven genes) selected from the combined data set after 
transformation by the proposed method.
Gene ID Gene name UniGene ID Symbol Chromosomal Location
AA485151 heat shock 105 kda/110 kda protein 1 Hs.36927 HSPH1 13q12.3
AA425217 cadherin 3, type 1, p-cadherin (placental) Hs.554598 CDH3 16q22.1
AA464731 s100 calcium binding protein a11 (calgizzarin) Hs.417004 S100A11 1q21
AA504130 cytoskeleton associated protein 2 Hs.444028 CKAP2 13q14
AA455925 four and a half lim domains 1 Hs.435369 FHL1 Xq26
AW050510 pyrroline-5-carboxylate reductase 1 Hs.458332 PYCR1 17q25.3
Comparison of the prediction accuracies Figure 2
Comparison of the prediction accuracies. The number by the name of each data set represents the sample size of the 
data set. Seven significant genes with high prediction accuracy were used.BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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F. Comparison of prediction accuracies of the proposed 
method in different platforms
The proposed method was evaluated using a NCI 60 cell
line data set, and the prediction accuracies of the pro-
posed method and the ME method were compared.
The prediction accuracies of both methods were com-
pared as the number of genes was increased to 300, and
they improved as the number of genes was increased,
regardless of train and test data sets (Figure 6A). The pre-
diction accuracies in the data sets that were transformed
by the ME method were greatly different according to the
train sets. The red and blue lines of Figure 6A displayed
more stable fluctuation in the prediction accuracies than
the green line, and they also showed similar patterns in
prediction accuracies.
When Oligo data was used for train, the variation in accu-
racies was relatively small and prediction accuracy was
high. It indicated that the Oligo data set predicted the
cDNA data set more stably and accurately than the cDNA
data set did. There was rare improvement in prediction
after 20 or 30 genes, and this showed that a small inform-
ative gene set is sufficient for discrimination. It was also
confirmed that the prediction accuracies were robust
against the train data sets in the proposed method, while
those in the ME method depended on the train data sets
and there was significant difference between them (Figure
6B).
Discussion
The designed 25-mer oligochips from Affymetrix provide
an absolute value of expression in an RNA sample, while
cDNA microarrays perform a two-color competitive
hybridization that gives the transcript expression in two
samples. Also, long oligonucleotide platforms (typically
60 to 80-mers) also use hybridization, the relative meas-
urements resulted in higher precision than did absolute
measurements on this platform [3]. Therefore, some
experimental biases can exist as a result of the differences
in the usage of absolute measurements and ratios.
Additionally, some previous studies indicated that the
data sets from different microarray platforms should not
be combined straightforwardly [24-27]. However, even
when the data sets were generated from the same plat-
form, the lab effect, especially when compounded with
the RNA sample effect, plays a bigger role than the plat-
form effect on data agreement [28].
There also exist inter-study biases among several microar-
ray data sets tested with different RNA sources even when
they are from the same laboratory and platform. Previous
studies showed that there were some differences in results
from data sets tested with different RNA sources, and the
sensitivity to detect differential gene expression from a
microarray data set using amplified RNA was also differ-
ent compared to using total RNA [29,30].
An attempt to combine these different types of data sets is
the usage of abstraction of expression values such as ranks
or discretized values [9-12]. These methods reduce the
variability in expression values from different microarray
data sets. While there may be a slight loss of information
by discretization, it is robust against outliers and fast and
simple to understand.
In colon cancer data sets derived from cDNA microarrays,
a data set created with total RNA predicted more accu-
Comparison of the prediction accuracies in ME method Figure 3
Comparison of the prediction accuracies in ME 
method.
Comparison of the prediction accuracies between the pro- posed method and the ME method Figure 4
Comparison of the prediction accuracies between 
the proposed method and the ME method.BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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rately a data set created using amplified RNA than vice
versa (Figure 2A). However, the data set, which was exper-
imented upon using amplified RNA, showed better per-
formance in the prediction of two test data sets than did a
data set from total RNA (Figure 2B). It can be interpreted
that the usage of same source can improve the prediction
power. Also, the combined data set predicted two test data
sets more accurately than did the separated data sets. With
the ME method, there existed some interaction between
test and train data sets even though it preserved high pre-
diction accuracies on test data sets (Figure 3). This indi-
cated that its prediction accuracy depended on test data
sets and was not stable. Consequently, a combined data
set by the proposed method showed the best performance
in the prediction of test data sets (Figure 4). The top six
discriminative genes selected from a combined data set,
which were not detected from two separated data sets,
were proven as genes associated with colon cancer by pre-
vious studies. Therefore, we believe that the usage of a
combined data set is more reliable to detect biologically
significant genes compared with separated data sets.
In the colon cancer data set derived from oligonucleotide
arrays, the prediction accuracies were improved by combi-
nation with cDNA data sets. Although two data sets
derived from different experimental conditions have dif-
ferent scales in gene expressions, such a different scale of
gene expressions could be compensated by discretizing
gene expression. Therefore, no transformation method
was required to match these two types of data sets except
only the ranking of gene expressions.
In the NCI 60 cell line data sets from two different plat-
forms, different types of two data sets were used by alter-
nating train and test data sets. The prediction accuracies in
datasets that were transformed by the ME method were
greatly different according to train sets, while those by the
proposed method were accompanied by stable fluctua-
tion in the prediction accuracies. The Oligo data set pre-
dicted the cDNA data set more stably and accurately than
vice versa. While the prediction accuracies in the ME
method depended on train and test data sets and the sig-
nificant difference existing between them, they were more
robust against train data in the proposed method (Figure
6B). In spite of the increase in the number of genes, the
prediction power was not improved after 20 or 30 genes,
and this indicated that small significant gene set is suffi-
cient to predict different experimental groups.
In this study, we transformed microarray data using ranks
of gene expressions to combine data sets created in differ-
ent experimental conditions. The proposed method may
be especially more useful to find discriminative genes
from data sets that have different scales of gene expression
ratios.
Methods
Data set
The data sets used in this study are summarized in Table 3.
Two cDNA microarray data sets, data A and data B, exper-
imented with 154 colorectal tissues (82 tumor and 72
normal) were used as train data sets for evaluation of the
proposed method. These two cDNA microarray data sets
derive from different RNA sources, which were total RNA
and amplified RNA. Previous studies have concluded that
there were differences between the results from these two
types of data sets and the sensitivity to detect differential
gene expression from microarray data sets using amplified
RNA was also different compared to using total RNA
[29,30]. It was also confirmed that systematic biases
Table 2: Summarization of cancer related genes selected from a combined data set http://david.abcc.ncifcrf.gov/.
Gene ID Gene name UniGene ID Symbol Chromosomal Location
Colon cancer related genes
N53057 chk1 checkpoint homolog (s. pombe) Hs.24529 CHEK1 11q24-q24
R19158 aurora kinase a Hs.250822 AURKA 20q13.2-q13.3
AA973748 fibrinogen silencer binding protein Hs.30561 RAD54B 8q21.3-q22, 8q22.1
AA446462 bub1 budding uninhibited by benzimidazoles 1 homolog (yeast) Hs.469649 BUB1 2q14
Cancer related genes
N71159 metastasis associated 1 Hs.525629 MTA1 14q32.3
AA913127 glucosaminyl (n-acetyl) transferase 2, i-branching enzyme (i blood group) Hs.519884 GCNT2 6p24
N53057 chk1 checkpoint homolog (s. pombe) Hs.24529 CHEK1 11q24-q24
AA664219 nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor) Hs.122926 NR3C1 5q31.3
AI337292 ttk protein kinase Hs.169840 TTK 6q13-q21
R19158 aurora kinase a Hs.250822 AURKA 20q13.2-q13.3
AA12698 myosin, heavy polypeptide 11, smooth muscle Hs.460109 MYH11 16p13.13-p13.12
AA446462 bub1 budding uninhibited by benzimidazoles 1 homolog (yeast) Hs.469649 BUB1 2q14
AA453176 ataxia telangiectasia and rad3 related Hs.271791 ATR 3q22-q24BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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existed between these two data sets using unsupervised
hierarchical cluster analysis [31].
Two more cDNA data sets, Tumor 86 and Tumor 211,
were experimented with amplified RNA and under differ-
ent batches, and they were used as test data sets. They
included only colon tumor tissues. These colon cancer
data sets performed with cDNA microarrays were from the
Cancer Metastasis Research Center of Yonsei University,
Seoul, Korea. One more colon cancer data set was used,
which was performed with the Human 6800 Gene Chip
Set (Affymetrix). It was obtained from microarray data-
base of Princeton University [32] and it included experi-
ments with the adenomas and their paired normal tissue
[33].
To evaluate the performance of the proposed method in
different platforms, NCI 60 cell line data sets derived from
different platforms were also used. Gene expression data
sets for NCI-60 using 9,706 cloned cDNA microarrays and
6,810 gene Affymetrix HU6800 oligonucleotide arrays
were obtained separately from the additional files of Lee
et al. [25], and the common 2,344 UniGene clusters were
used for this study. Ovarian and colon cancer cell lines
were used for this study among nine tumor cell lines, and
these two groups included six and seven replications.
Transformation method of gene expression ratios
Data preprocessing
Gene expression ratios were normalized such that they
would have similar distributions across a series of arrays
and the normalization process was executed using the
'limma' library of the R package [34]. The cDNA data in
the NCI 60 cell line data sets included missing entries, and
these were estimated by using the SeqKnn (Sequential k
nearest neighbor) imputation method [35] before analy-
sis.
Discretization by proposed method using rank of gene expression
For transformation of the data set, gene expression ratios
are rearranged in order of expression ratios by each gene,
and the ranks are matched with the corresponding exper-
imental group. If the experimental groups are homoge-
nous, the ranks within the same experimental group
would be neighboring. This process can be seen as similar
to the first step in the nonparametric Mann-Whitney U
test. The process of discretization of gene expressions is
summarized in the following steps:
(1) Rank the gene expression ratios within a gene for each
data set.
(2) List in order of the ranks and assign the order of gene
expressions to the corresponding experimental groups.
(3) Summarize the result of (2) in the form of a contin-
gency table for each gene.
(4) Test the relationship between the gene expression pat-
terns and experimental groups for each gene.
When there are three data sets to be combined, the data
sets can be added by each entry as shown in Table 4 after
the transformation of each data set by rank.
Discretization of expression ratios using recursive minimal entropy
A method for discretizing continuous attributes based on
a minimal entropy (ME) heuristic, presented by Catlett
Comparison of prediction accuracies of single and combined data sets Figure 5
Comparison of prediction accuracies of single and combined data sets.BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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[36] and Fayyad and Irani [10], was compared with the
proposed method in the experimental study. The algo-
rithm uses the class information entropy of candidate par-
titions to select binary boundaries for discretization. If
there is a given set of instances S, a feature A, and a parti-
tion boundary T, the class information entropy of the par-
tition induced by T, denoted E(A, T, S) is given by:
For a given feature A, the boundary Tmin, which minimizes
the entropy function over all possible partition bounda-
ries, is selected as a binary discretization boundary. This
method can be applied recursively to both of the parti-
tions induced by Tmin until some stopping condition is
achieved, thus creating multiple intervals on feature A. It
must be evaluated N-1 times for each attribute with N the
number of attribute values [37]. The library 'dprep' in R
[34] was used for this method.
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Table 3: Colon cancer data sets for train and test (genes with missing entries were excluded).
Data name Experimental sources # of genes # of total samples Normal group Tumor group
Train data sets a
Data A Total RNA 12319 78 35 43
Data B Amplified RNA 12319 76 37 39
Data AB Combined data set 12319 154 72 82
Test data sets a
Tumor 86 Amplified RNA (Batch I) 17104 86 0 86
Tumor 211 Amplified RNA (Batch II) 17104 211 0 211
Train and Test data set (Notterman et al., 2001)
Affy Affymetrix HU6800 7464 36 18 18
a: Cancer Metastasis Research Center of Yonsei University, Seoul, Korea.
Comparison of prediction accuracies under conditions of two test data sets and the number of informative genes Figure 6
Comparison of prediction accuracies under conditions of two test data sets and the number of informative 
genes. (A) Blue: test Oligo data with cDNA by proposed method; Red: test cDNA data with Oligo data by proposed method; 
Green: test Oligo data with cDNA by ME method; Cyan: test cDNA data with Oligo data by ME method. (B) Summary of pre-
diction accuracies using a boxplot. cDNA_R and Oligo_R are data sets transformed by the proposed method. cDNA_ME and 
Oligo_ME are data sets transformed by the ME method.BMC Bioinformatics 2008, 9:283 http://www.biomedcentral.com/1471-2105/9/283
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Nonparametric method for significant gene selection
After the summarization of gene expression ratios in the
form of a contingency table for each gene, as shown in
Table 5, a nonparametric statistical method was applied
to the data sets for independency testing between gene
expression patterns and experimental groups. The test sta-
tistics are calculated as follows for each gene:
When the sample size for each experiment is small, gener-
ally less than five, Fisher's exact test is recommended
rather than the Chi-square test.
Classification method to evaluate the informative gene set 
selected from the combined data set
In order to evaluate the predictive accuracy of the selected
significant gene set, the Random Forest (RF) test [38] was
used to enable re-sampling while allowing repetition. The
RF program in the R package [34] was used and it works
using the following steps:
(1) Generate n data sets of bootstrap samples {B1, B2, ...,
Bn} by allowing repetition. (2) Use a Bk to build a tree
classifier Tk, and classify Bms (m≠k) data (out-of-bag
(OOB) samples). (3) Calculate classification errors of Bms
and obtain an average for them which is the overall classi-
fication error (OOB error). (4) Calculate the prediction
accuracy of test data sets using the classifier built in (2).
Abbreviations
ANOVA: Analysis Of Variance; OOB error: Out Of Bag
error; ME: Minimal Entropy.
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data set A data set B data set C combined data set
P1, P2 and P3 represent the three different phenotypes. E1, E2 and E3 represent three groups by ranks of gene expressions. aij, bij and cij are the 
numbers of experiments belong to Pj and Ei at the same time in data A, data B and data C, respectively.Publish with BioMed Central    and   every 
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